Related Experiment Video
Updated: Apr 8, 2026

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
The search for novel analgesics: targets and mechanisms
Tony L Yaksh1, Sarah A Woller1, Roshni Ramachandran1
1University of California, San Diego, Department of Anesthesiology 0818 9500 Gilman, Dr. (CTF C-312), La Jolla, CA 92093 USA.
Abstract:
The management of the pain state is of great therapeutic relevance to virtually every medical specialty. Failure to manage its expression has deleterious consequence to the well-being of the organism. An understanding of the complex biology of the mechanisms underlying the processing of nociceptive information provides an important pathway towards development of novel and robust therapeutics. Importantly, preclinical models have been of considerable use in determining the linkage between mechanism and the associated behaviorally defined pain state. This review seeks to provide an overview of current thinking targeting pain biology, the use of preclinical models and the development of novel pain therapeutics. Issues pertinent to the strengths and weaknesses of current development strategies for analgesics are considered.
Insights
Understanding pain biology and utilizing preclinical models are crucial for developing new pain therapeutics. This review examines current strategies and their limitations in analgesic drug development.
Area of Science:
- Pain research
- Neuroscience
- Pharmacology
Background:
- Effective pain management is critical across medical specialties.
- Understanding nociceptive processing is key to novel therapeutic development.
- Preclinical models are vital for linking biological mechanisms to pain states.
Purpose of the Study:
- To review current understanding of pain biology.
- To discuss the utility of preclinical models in pain research.
- To explore novel pain therapeutic development strategies.
Main Methods:
- Literature review of pain biology mechanisms.
- Analysis of preclinical models for pain assessment.
- Evaluation of current analgesic development strategies.
Main Results:
- Pain processing involves complex biological mechanisms.
- Preclinical models aid in understanding mechanism-behavior relationships.
- Current analgesic development faces challenges and limitations.
Conclusions:
- Advancing pain therapeutics requires a deep understanding of pain biology.
- Optimizing preclinical models is essential for translational success.
- Addressing limitations in current strategies can accelerate the development of effective analgesics.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Nociception
Opioid Analgesics: Morphine and Other Natural Cogeners
Pain
Opioid Receptors: Overview

